Live Breaking News & Updates on Nfl Biosciences

Stay updated with breaking news from Nfl biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nfl Biosciences: Patent Application Filed in the United

NFL BIOSCIENCES: PATENT APPLICATION FILED IN THE UNITED STATES FOR REDUCING ALCOHOL CONSUMPTION WITH NFL-301 & PREPARATION OF A PRE-IND APPLICATION. ....

United States , Mclean Hospital , Athena Pharmaceutiques , Scott Lukas , Bruno Lafont , Francis Ahner , Agence Calyptus , Behavioral Psychopharmacology Research Laboratory , Drug Administration , Euronext Growth Paris , Mclean Hospital Imaging Center , Harvard Medical School , Chief Operating Officer , Pre Investigational New Drug , Paris Stock Exchange Alnfl , Nfl Biosciences ,

NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY'S

NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY’S CAPITAL UPON THE EXERCISE OF SHARE SUBSCRIPTION WARRANTS AND PAYMENT OF 0.5M€, AND ALSO COMMITS. ....

Bruno Lafont , Ignacio Faus , Agence Calyptus , Gb Holding , Euronext Growth Paris , Central Nervous System , Hospital Injectables , Invest Securities , Financial Report , Paris Stock Exchange Alnfl , Nfl Biosciences ,

NFL Biosciences: 2022 full-year business and earnings

NFL Biosciences: 2022 full-year business and earnings update Phase II/III clinical trial for the drug candidate NFL-101 for smoking cessation: 100% of. ....

United States , Clermont Ferrand , South Korea , France General , Poitou Charentes , United Arab Emirates , Ignacio Faus , Agence Calyptus , Institut Pasteur , Bruno Lafont , European Medicines Agency , Health Products , Atomic Energy Commission , Clinical Investigation Centers , Food Drug Administration , Themis Medicare Ltd , Euronext Growth Paris , Chief Executive Officer , French National Agency , French Ethical Review Board , Drug Administration , French State , Themis Medicare , French Alternative Energies , Saclay Pharmacological Neuroimaging , General Meeting ,

NFL Biosciences launches a round of fundraising for

NFL Biosciences launches a round of fundraising for approximately 2.5 million euros Capital increases as part of a global offer comprising an offer. ....

United States , Ignacio Faus , Institut Pasteur , European Medicines Agency , Us Food Drug Administration , Drug Administration , Primarybid Offer , Euronext Growth Paris , Reserved Offer , Extraordinary General Meeting , Paris Stock Exchange Alnfl , Nfl Biosciences ,

NFL BIOSCIENCES: Decision to approve the issuing of its

NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a. ....

United States , United Arab Emirates , Saudi Arabia , South Korea , South Korean , Bruno Lafont , Agence Calyptus , Euronext Growth Paris , Chief Operating Officer , Paris Stock Exchange Alnfl , Nfl Biosciences ,